Virtual reality education for patients with arterial hypertension
A Pilot Study of the Feasibility and Non-inferiority of Patient Education About Arterial Hypertension in Virtual Reality
This study tests whether virtual reality education can teach people with high blood pressure just as well as traditional in-person education from a doctor.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Poliklinika Agel, Dopravni zdravotnictvi a.s. Academic / other |
| Locations | 1 site (Ostrava) |
| Trial ID | NCT05735808 on ClinicalTrials.gov |
What this trial studies
This study compares traditional education methods with virtual reality (VR) augmented education for patients diagnosed with arterial hypertension. Patients will be randomly assigned to receive education either through a physician in person or via a 3D VR experience created by a physician. The study aims to assess the feasibility, non-inferiority, and cost-effectiveness of VR education compared to standard methods. Outcomes will be evaluated through questionnaires measuring patient satisfaction and educational effectiveness.
Who should consider this trial
Good fit: Ideal candidates are patients diagnosed with arterial hypertension who are attending an internal medicine outpatient clinic.
Not a fit: Patients with visual impairments may not benefit from this study due to the reliance on visual content in VR education.
Why it matters
Potential benefit: If successful, this approach could enhance patient understanding and management of arterial hypertension through innovative educational methods.
How similar studies have performed: While the use of VR in medical education is gaining traction, this specific approach comparing VR to traditional methods in hypertension education is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * all consecutive patients with arterial hypertension Exclusion Criteria: * visual impairment
Where this trial is running
Ostrava
- Poliklinika Agel — Ostrava, Czechia (Recruiting)
Study contacts
- Study coordinator: Bogna Jiravska Godula, MD
- Email: Bogna.jiravska-godula@npo.agel.cz
- Phone: +420602579193
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.